Experiment 665381

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

BRYOSTATIN 1

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIV
OrganismEmpty organism
CitationVARTERASIAN,ML: MOHAMMAD,RM: SHURAFA,MS: HULBURD,K: PEMBERTON,PA: RODRIGUEZ,DH: SPADONI,V: EILENDER,DS: MURGO,A: WALL,N: DAN,M: AL-KATIB,AM:. (2000). PHASE II TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH RELAPSED LOW-GRADE NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA.. 6(3)
Amount utilized
Compound isolated
DiseaseIN PATIENTS WITH NON-HODGKINS LYMPHOMA OR LYPHOCYTIC LEUKEMIA
Dose amount120.0 MCG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M
Dose expressionDOSE